Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells

  • Authors:
    • Esther Dos Santos
    • Delphine Benaitreau
    • Marie-Noëlle Dieudonne
    • Marie-Christine Leneveu
    • Valérie Serazin
    • Yves Giudicelli
    • René Pecquery
  • View Affiliations

  • Published online on: October 1, 2008     https://doi.org/10.3892/or_00000098
  • Pages: 971-977
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Numerous epidemiological studies have documented that obesity is a risk factor for breast cancer especially in post-menopausal women. However, the molecular basis of this association is not well known. In contrast to leptin, plasma levels of adiponectin, another major adipokine, are decreased in obese subjects. Therefore, we and others hypothesized that adiponectin may be a paracrine factor negatively controlling mammary tumor development. We recently demonstrated growth inhibition of the estrogen-sensitive breast cancer MCF-7 cell line by adiponectin. The purpose of the present study was to determine whether this anti-proliferative effect of adiponectin also applies to the MDA-MB 231 estrogen-insensitive breast epithelial cancer cell line. Our results demonstrate that i) the adiponectin-specific receptors AdipoR1 and R2 are expressed in these cells, and ii) the subphysiological concentrations of recombinant adiponectin inhibit MDA-MB 231 cell growth and concomitantly enhance the expression of Bax and p53, two pro-apoptotic genes. Moreover, the invalidation of AdipoR1 and R2 mRNA experiments demonstrated that the anti-proliferative and pro-apoptotic effects of adiponectin were partially mediated via AdipoR1 and R2. We describe, for the first time, that AdipoR mRNA expression was down-regulated by adiponectin and leptin in MDA-MB 231 cells. Taken altogether, these results strongly suggest that the two adipokines should be considered as i) additional factors of breast cancer risk, and ii) may therefore be potential targets in breast cancer therapy.

Related Articles

Journal Cover

October 2008
Volume 20 Issue 4

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Dos Santos E, Benaitreau D, Dieudonne M, Leneveu M, Serazin V, Giudicelli Y and Pecquery R: Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells. Oncol Rep 20: 971-977, 2008
APA
Dos Santos, E., Benaitreau, D., Dieudonne, M., Leneveu, M., Serazin, V., Giudicelli, Y., & Pecquery, R. (2008). Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells. Oncology Reports, 20, 971-977. https://doi.org/10.3892/or_00000098
MLA
Dos Santos, E., Benaitreau, D., Dieudonne, M., Leneveu, M., Serazin, V., Giudicelli, Y., Pecquery, R."Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells". Oncology Reports 20.4 (2008): 971-977.
Chicago
Dos Santos, E., Benaitreau, D., Dieudonne, M., Leneveu, M., Serazin, V., Giudicelli, Y., Pecquery, R."Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells". Oncology Reports 20, no. 4 (2008): 971-977. https://doi.org/10.3892/or_00000098